Ocumension Therapeutics (FRA:5DG)
Germany
· Delayed Price · Currency is EUR 0.8900
+0.0100 (1.14%)
Last updated: Dec 5, 2025, 10:30 AM CET
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of €747.30 million as of December 5, 2025. Its market cap has increased by 48.19% in one year.
Market Cap
747.30M
Enterprise Value
687.40M
Revenue
64.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.89
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 2.43B to 747.30M, a decrease of -69.21%. That is a compound annual growth rate of -19.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 747.30M | 63.73% |
| Dec 31, 2024 | 456.43M | -14.58% |
| Dec 29, 2023 | 534.31M | -32.64% |
| Dec 30, 2022 | 793.26M | -39.71% |
| Dec 31, 2021 | 1.32B | -21.82% |
| Dec 31, 2020 | 1.68B | -30.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |